Teva Wants Out of Case Targeting Blockbuster MS Drug

By Greg Lamm · March 9, 2023, 8:02 PM EST

Teva Pharmaceuticals Ltd. said Thursday it should be able to escape insurance payor claims alleging an elaborate campaign to suppress generic competition for Teva's multiple sclerosis drug Copaxone, arguing the claims...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

King County et al v. Teva Pharmaceutical Industries Ltd et al

Case Number

2:21-cv-00477

Court

Washington Western

Nature of Suit

Racketeer/Corrupt Organization

Date Filed

April 08, 2021